/PRNewswire/ Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced.
MIL-OSI: Brandon Capital Joins AstronauTx' £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer's disease foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced.